We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+12.71%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$322M
Cap. Flow
+$229M
Cap. Flow %
16.07%
Top 10 Hldgs %
6.36%
Holding
2,241
New
645
Increased
572
Reduced
474
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.4M
2
NVDA icon
NVIDIA
NVDA
+$12.7M
3
MSFT icon
Microsoft
MSFT
+$11.3M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.44M
5
JPM icon
JPMorgan Chase
JPM
+$6.53M

Top Sells

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$4.12M
2
BX icon
Blackstone
BX
+$3.99M
3
KLG
WK Kellogg Co
KLG
+$3.21M
4
CALM icon
Cal-Maine
CALM
+$2.92M
5
FRO icon
Frontline
FRO
+$2.74M

Sector Composition

Rank Sector Weight
1 Technology 18.54%
2 Financials 15.47%
3 Healthcare 14.21%
4 Industrials 11.6%
5 Consumer Discretionary 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCYX icon
1676
SCYNEXIS
SCYX
$52M
$36K ﹤0.01%
+6,688
New +$46.9K
ALXO icon
1677
ALX Oncology
ALXO
$283M
$34K ﹤0.01%
+81,326
New +$41K
BRY
1678
DELISTED
Berry Corp
BRY
$33K ﹤0.01%
11,895
-131,417
-92% -$351K
WDH
1679
Waterdrop
WDH
$359M
$33K ﹤0.01%
+24,112
New +$32.6K
YCBD icon
1680
cbdMD
YCBD
$5.93M
$33K ﹤0.01%
37,465
+33,495
+844% +$44K
SND icon
1681
Smart Sand
SND
$194M
$32K ﹤0.01%
15,931
+2,947
+23% +$5.96K
TRUE
1682
DELISTED
TrueCar
TRUE
$32K ﹤0.01%
16,778
-88,092
-84% -$134K
EAF icon
1683
GrafTech
EAF
$212M
$29K ﹤0.01%
2,983
+1,767
+145% +$15.6K
ADV icon
1684
Advantage Solutions
ADV
$361M
$28K ﹤0.01%
+835
New +$27.5K
HGBL icon
1685
Heritage Global
HGBL
$36.8M
$24K ﹤0.01%
+10,802
New +$22.6K
GANX icon
1686
Gain Therapeutics
GANX
$77.6M
$23K ﹤0.01%
+12,756
New +$23.6K
BORR
1687
Borr Drilling
BORR
$1.19B
$22K ﹤0.01%
12,229
-103,964
-89% -$196K
VXRT
1688
DELISTED
Vaxart
VXRT
$22K ﹤0.01%
+48,548
New +$21.1K
YARW
1689
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$22K ﹤0.01%
+269
New +$17.5K
GGRP
1690
Glimpse Group
GGRP
$18.7M
$20K ﹤0.01%
14,956
– –
RMTI icon
1691
Rockwell Medical
RMTI
$28.2M
$19K ﹤0.01%
+2,231
New +$22.7K
CCCC icon
1692
C4 Therapeutics
CCCC
$412M
$16K ﹤0.01%
10,963
-32,978
-75% -$48K
PLRX icon
1693
Pliant Therapeutics
PLRX
$65M
$16K ﹤0.01%
14,142
-20,530
-59% -$29K
RANI icon
1694
Rani Therapeutics
RANI
$89M
$13K ﹤0.01%
25,391
-19,242
-43% -$15.7K
BKYI
1695
BIO-key International
BKYI
$4.38M
$11K ﹤0.01%
+1,331
New +$10.5K
AA icon
1696
Alcoa
AA
$13.2B
– –
-31,190
Closed -$951K
ABCB icon
1697
Ameris Bancorp
ABCB
$5.89B
– –
-8,790
Closed -$506K
ABEO icon
1698
Abeona Therapeutics
ABEO
$413M
– –
-63,835
Closed -$304K
ABG icon
1699
Asbury Automotive
ABG
$3.85B
– –
-1,461
Closed -$323K
ABM icon
1700
ABM Industries
ABM
$2.84B
– –
-8,981
Closed -$425K
66 67
68
69 70

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, GSA Capital Partners held 2,241 positions worth $1.43B, up 29% from $1.11B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

GSA Capital Partners deployed $229M of net new capital in Q2 2025, opening 645 new positions and adding to 572 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 16,625 shares worth $8.08M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CSX Corp, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q2 2025 buy was Berkshire Hathaway Class B: 16,625 shares worth $8.08M.
  • GSA Capital Partners added most to Apple in Q2 2025, an estimated $13.4M increase.
  • GSA Capital Partners's biggest Q2 2025 reduction was CSX Corp, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited WK Kellogg Co in Q2 2025, selling an estimated $3.21M.
  • GSA Capital Partners's ten largest holdings make up 6.4% of its $1.43B portfolio in Q2 2025.
  • GSA Capital Partners opened 645 new positions and closed 546 in Q2 2025.
  • GSA Capital Partners's portfolio value rose 29% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.